Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces 1000 patients treated with the DETOUR™ System.

See Release

All News

Archives

Endologix Appoints John D. Zehren as Chief Commercial Officer

Endologix Takes Decisive Action to Optimize Patient Outcomes by Ensuring Nellix System Used Only within Current Indications

Endologix Honors Innovators of Aortic Therapy at VEITHsymposium

FDA Classifies Previous Endologix AFX Safety Notice as Class I Recall

Endologix Announces Third Quarter Preliminary Revenue Results and Raises Low End of 2018 Revenue Guidance Range